Evolus Inc (EOLS)
NASDAQ:EOLS

Evolus (EOLS) Stock Forecast & Price Target

324 Followers
See the Price Targets and Ratings of:

EOLS Analyst Ratings

Strong Buy
3Ratings
3 Buy
0 Hold
0 Sell
Based on 3 analysts giving stock ratings to
Evolus
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

EOLS Stock 12 Months Forecast

Average Price Target

$17.00
▲(133.52% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Evolus in the last 3 months. The average price target is $17.00 with a high forecast of $18.00 and a low forecast of $15.00. The average price target represents a 133.52% change from the last price of $7.28.
Highest Price Target$18.00Average Price Target$17.00Lowest Price Target$15.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Mizuho Securities
$15.00
Buy
106.04%
Upside
Reiterated
Mizuho Securities Keeps Their Buy Rating on Evolus (EOLS)
Barclays
$10.00
Hold
37.36%
Upside
Upgraded
Evolus upgraded to Equal Weight from Underweight at BarclaysEvolus upgraded to Equal Weight from Underweight at Barclays
Truist Financial
$13.00
Buy
78.57%
Upside
Reiterated
Evolus (EOLS) PT Raised to $13 at Truist SecuritiesTruist Securities analyst Gregg Gilbert raised the price target on Evolus (NASDAQ: EOLS) to $13.00 (from $11.00) while maintaining a Buy rating.
Cantor Fitzgerald
$20.00
Buy
174.73%
Upside
Reiterated
Cantor Fitzgerald reiterates Overweight Rating on Evolus (EOLS), Jeuveaus Value Proposition is UnderappreciatedCantor Fitzgerald analyst Louise Chen reiterated an Overweight rating and $20.00 price target on Evolus (NASDAQ: EOLS), following the companys Q4 report.
Stifel Nicolaus
$20.00
Buy
174.73%
Upside
Reiterated
Evolus preannouncement shows continued execution success, says StifelEvolus preannouncement shows continued execution success, says Stifel
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

EOLS Financial Forecast

EOLS Earnings Forecast
Next quarter’s earnings estimate for EOLS is -$0.19 with a range of -$0.26 to -$0.12. The previous quarter’s EPS was -$0.28. EOLS beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.38% of the time in the same period. In the last calendar year EOLS has Underperformed its overall industry.
Next quarter’s earnings estimate for EOLS is -$0.19 with a range of -$0.26 to -$0.12. The previous quarter’s EPS was -$0.28. EOLS beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.38% of the time in the same period. In the last calendar year EOLS has Underperformed its overall industry.
EOLS Sales Forecast
Next quarter’s sales forecast for EOLS is $42.95M with a range of $39.58M to $44.42M. The previous quarter’s sales results were $33.90M. EOLS beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 42.90% of the time in the same period. In the last calendar year EOLS has Outperformed its overall industry.
Next quarter’s sales forecast for EOLS is $42.95M with a range of $39.58M to $44.42M. The previous quarter’s sales results were $33.90M. EOLS beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 42.90% of the time in the same period. In the last calendar year EOLS has Outperformed its overall industry.
EOLS Analyst Recommendation Trends
In the current month, EOLS has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The EOLS average analyst price target in the past 3 months is $17.00
In the current month, EOLS has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The EOLS average analyst price target in the past 3 months is $17.00

EOLS Stock Forecast FAQ

What is EOLS’s average 12-month price target, according to analysts?
Based on analyst ratings, Evolus’s 12-month average price target is $17.00.
    What is EOLS’s upside potential, based on the analysts’ average price target?
    Evolus has 133.52% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is EOLS a Buy, Sell or Hold?
          Evolus has a conensus rating of Strong Buy which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Evolus’s price target?
            The average price target for Evolus is $17.00. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $18.00 ,the lowest forecast is $15.00. The average price target represents 133.52% Increase from the current price of $7.28.
              What do analysts say about Evolus?
              Evolus’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis